We investigated the effects of,, 8, and #c opioid receptor stimulation on the contractile properties and cytosolic Ca2' (Cal) of adult rat left ventricular myocytes. Cells were fieldstimulated at 1 Hz in 1.5 mM bathing Ca2+ at 23°C. The,oll-enkephalin (10-`M) had no effect on the twitch. The a-agonists methionine enkephalin and leucine enkephalin (10-10 to 10-6 M) and the c-agonist (trans-(dl)-3,4-dichloro-N-methyl-N- [2-(1-pyrrolidinyl)cyclo-hexyll-benzeneacetamide)methanesulfonate hydrate (U-50,488H; 10-7 to 2 x 10-5 M) had a concentration-dependent negative inotropic action. The sustained decrease in twitch amplitude due to U-50,488H was preceded by a transient increase in contraction. The effects of t-and K-receptor stimulation were antagonized by naloxone and (-)-N-(3-furylmethyl)-ce-normetazocine methanesulfonate, respectively. In myocytes loaded with the Ca21 probe indo-1, the effects of leucine enkephalin (10-`M) and U-50,488H (10-`M) on the twitch were associated with similar directional changes in the Caj transient. Myofilament responsiveness to Ca2' was assessed by the relation between twitch amplitude and systolic indo-1 transient. Leucine enkephalin (10-8 M) had no effect, whereas U-50,488H (10-`M) increased myofilament responsiveness to Ca2`. We 
oll-enkephalin (10-`M) had no effect on the twitch. The a-agonists methionine enkephalin and leucine enkephalin (10-10 to 10-6 M) and the c-agonist (trans-(dl)-3,4-dichloro-N-methyl-N- [2- (1-pyrrolidinyl)cyclo-hexyll-benzeneacetamide)methanesulfonate hydrate (U-50,488H; 10-7 to 2 x 10-5 M) had a concentration-dependent negative inotropic action. The sustained decrease in twitch amplitude due to U-50,488H was preceded by a transient increase in contraction. The effects of t-and K-receptor stimulation were antagonized by naloxone and (-)-N-(3-furylmethyl)-ce-normetazocine methanesulfonate, respectively. In myocytes loaded with the Ca21 probe indo-1, the effects of leucine enkephalin (10-`M) and U-50,488H (10-`M) on the twitch were associated with similar directional changes in the Caj transient. Myofilament responsiveness to Ca2' was assessed by the relation between twitch amplitude and systolic indo-1 transient. Leucine enkephalin (10-8 M) had no effect, whereas U-50,488H (10-`M) increased myofilament responsiveness to Ca2`. We subsequently tested the hypothesis that a andic opioid receptor stimulation may cause sarcoplasmic reticulum Ca2' depletion. The sarcoplasmic reticulum Ca21 content in myocytes and in a caffeine-sensitive intracellular Ca2' store in neurons was probed in the absence of electrical stimulation via the rapid addition of a high concentration of caffeine from a patch pipette above the cell. U-50,488H and leucine enkephalin slowly increased Ca; or caused Caj oscillations and eventually abolished the caffeine-triggered Caj transient. These effects occurred in both myocytes and neuroblastoma-2a cells. In cardiac myocyte suspensions U-50,488H and leucine enkephalin both caused a rapid and sustained increase in inositol 1,4,5-trisphosphate. Thus 9 It has also been suggested that opioids may reach the heart either via the systemic circulation,10,11 when released from the adrenal medulla,12-15 or more directly, when coreleased with other neurotransmitters from the nerve endings distributed within the cardiac tissue. [16] [17] [18] [19] [20] [21] Recently, large amounts of mRNA for preproenkephalin A have been identified in the rat ventricle,22 in cultured rat ventricular myocytes,23 and in the hamster heart,24 which raises the possibility that the cardiac myocyte may be capable of synthesizing opioid peptides. These reports suggest that the myocardium may be exposed to opioid receptor agonists in vivo, and from binding studies there is evidence that opioid receptors are present in rat cardiac sarcolemma. 25 However, the effect of opioid peptides on myocardial function is still poorly defined. The role of each of the three opioid receptors, g, K, and 8, to modulate the contraction of the myocardial cell was initially assessed in experiments with specific agonists and antagonists in myocytes not loaded with indo-1.
The selective ,u-agonist DAGO had no effect on twitch amplitude at concentrations up to 10-5 M ( Figure 1A ). In contrast, both methionine enkephalin ( Figure 1B ) and leucine enkephalin ( Figure 1C ), which bind predominantly to the 8-receptor and to a much smaller extent to the g-receptor, had a significant negative inotropic action. The selective synthetic K-agonist U-50,488H had a biphasic effect on contraction that increased transiently before a progressive diminution and also decreased diastolic cell length (Figure iD) .
It is noteworthy that the response to the 8-and K-agonists differed in several ways. Methionine enkephalin and leucine enkephalin caused a monotonic decrease in the amplitude of the twitch ( Figures 1B  and 1C ), whereas U-50,488H had a biphasic effect; that is, a transient increase in twitch amplitude preceded the negative inotropic action ( Figure 1D ). The K-agonist, unlike the 8-agonists, caused a reduction of diastolic cell length (dotted line in Figure 1D ). Finally, washout of methionine enkephalin ( Figure  1B ) and leucine enkephalin ( Figure 1C , lower tracing) did not reverse their negative inotropic effect unless concentrations as low as 10`10 M were used ( Figure 1C , upper tracing for leucine enkephalin). In contrast, the negative inotropic effect of U-50,488H
was reversible even at concentrations as high as 10M
( Figure 1D ). Opioid receptor blockers were used to assess the specificity of the response to the 8-and K-agonists. Figure 2 shows that naloxone and Mr 1452,-which the addition of naloxone during exposure to saturating concentrations of 8 opioid receptor agonists reversed the negative inotropic action of these substances (not shown). Figure 3A shows the concentration-response curve for the effect of methionine enkephalin, leucine enkephalin, and U-50,488H on the contractile properties of ventricular myocytes. Methionine enkephalin and leucine enkephalin had a concentration-dependent negative inotropic action that became evident at 10-10 M, saturated at 10 8 M, and was associated with a prolongation of the time course of the contraction. Methionine enkephalin at 10-6 M decreased the amplitude of the contraction to 42 .0+±5.3% of control and prolonged the time to 90% relaxation to 176.0+7.5% of control. Leucine enkephalin at 10-6 M decreased the amplitude of the contraction to 18.9+4.0% of control and prolonged the time to 90% relaxation to 248.1 +±16.6% of control. The negative inotropic effect of 10-6 M leucine enkephalin was significantly more marked than that of 10-6 M methionine enkephalin. The negative inotropic effect of U-50,488H became apparent at 10`7 M and saturated at 10-5 M. At 2x10-5 M the K-agonist decreased twitch amplitude to 8.6+3.9% of control and prolonged the time to 90% relaxation to 192.2+21.4% of control. The negative inotropic effect of 2x 10-5 M U-50,488H was more pronounced than that of 10-6 M methionine enkephalin but not statistically different from that of 10-6 M leucine enkephalin. Figure 3B shows the average time course of the effect of 10 8 M methionine enkephalin, 10 8 M leucine enkephalin, and 10-5 M U-50,488H on twitch characteristics. The decrease in the amplitude of the contraction and the prolongation of the time to 90% relaxation produced by methionine enkephalin was already evident within the initial 5 minutes of exposure to the opioid, and no further decrease in twitch amplitude occurred after 15 minutes of superfusion. TiME, mln
The effect of 10 8 M leucine enkephalin on the twitch was noticeable after 1 minute of exposure. The time course of the decrease in the amplitude of the contraction caused by leucine enkephalin was faster than that caused by a similar concentration of methionine enkephalin.
The response to U-50,488H (10-5 M) occurred more rapidly than the response to either 8-agonist. It is noteworthy that the transient increase in twitch amplitude depicted in Figure 1 represents a consistent finding of the response to U-50,488H. However, this increase occurred shortly after exposure to the K-agonist, and it usually resolved within 1 minute. For this reason, it is not reflected in the average data in Figure 3B .
To determine whether the changes in twitch contraction caused by 8 In other experiments we used the endogenous K-selective agonist dynorphin to assess whether its actions were qualitatively similar to those of U-50,488H. Because dynorphin A (fragment 1-17) is unstable and may stick to the plastic tubing used for superfusion,52 it was directly injected into the bathing medium from a glass micropipette placed above the myocyte. This technique is described in detail in a subsequent section of the present article; its limitation is that it does not allow a close control of the concentration of the agonist to which the cell is exposed, because significant dilution occurs after its injection into the bathing medium. Figure 6 A similar relation between resting indo-1 ratio and cell length was also observed in some cells exposed to U-50,488H. These findings are consistent with the enhancement of myofilament responsiveness to Ca2+ produced by K opioid receptor stimulation.
Effect of 8 Figure  8C ). In Figure 9 is shown the result of a similar experiment with the opioid receptor agonist leucine enkephalin. Perfusion of a representative myocyte with leucine enkephalin triggered Caj oscillations,39,61,62 which were manifested as spikes in the fluorescence signal, and abolished the caffeine-induced indo-1 transient ( Figure 9A ). These effects of leucine enkephalin were prevented by naloxone ( Figure 9B ).
We next inquired whether the K-and 8-agonistinduced release of Ca>2 from an intracellular pool represents a general mechanism for the action of opioids and whether this release also occurred in neuronal cells. Figure 1OA shows that neuroblastoma-2a cells responded to caffeine with a rapid increase in Cai. The Caj transient observed under these conditions was due to endogenous release of Ca> leaving a smaller concentration of Ca2' than that in control available for release by caffeine. In contrast, when the K-agonist was perfused with its antagonist, Mr 1452, there was no effect on indo-1 fluorescence, and the subsequent caffeine-induced Caj transient was like that in control ( Figure 1OC ). Similar results were obtained with leucine enkephalin ( Figure  HA) , whose effects were blocked by naloxone (Figure liB) . whereas in at least another instance, no effect was found.27 However, those experimental designs used either intact animals, isolated and perfused hearts, papillary muscles, or muscle strips. Under those circumstances, the experimental results are likely to be affected by changes in preload, afterload, coronary flow, and heart rate and by the effect of opioid peptides to presynaptically modulate the release of norepinephrine and acetylcholine from the nerve endings. [1] [2] [3] [4] [5] [6] [7] [8] In the present study, we show that 8 and K opioid receptor agonists have a negative inotropic action on isolated left ventricular myocytes, whereas ,u opioid receptor stimulation has no significant effect on the contractile properties of these myocardial cells. This finding is in agreement with a recent report that has demonstrated, in sarcolemmal rat preparations, the existence of 8-and K-but not g-receptors. 25 We also show that leucine enkephalin and U-50,488H cause release and depletion of Ca21 from the SR and trigger a rapid and sustained rise in 1P3 production.
Release of Ca21 from an endogenous pool, leading to an increase in Cai, Caj oscillations, and depletion of the storage site, was also observed in neuroblastoma-2a cells. In addition, significant differences exist between 8 Figure 10A ). These effects of leucine enkephalin were prevented when naloxone (1 pM) was perfused with leucine enkephalin (panel B Homeostasis 79 minute, when the experiment was terminated. In a subsequent report, the same authors related this result to an increase in cell Ca'4 loading mediated by an enhancement in adenylate cyclase activity and cAMP levels. 35 In contrast, in a similar preparation, others have described that opioid receptor stimulation decreases cAMP, increases cGMP, and markedly inhibits the effect of norepinephrine to stimulate cAMP and reduce cGMP. 89 In rat brain homogenate, morphinelike substances were reported to inhibit hormonally stimulated cAMP formation without affecting its basal production,65 and a similar action on adenylate cyclase activity and cAMP levels has been reported in other neuronal cell types.64 '66 In unstimulated cardiac myocytes, an increase in cAMP would be expected to enhance SR Ca'+ uptake67, 68 (Tables  1 and 2 ). Thus, it is unclear which role, if any, a change in cAMP and/or cGMP might have had in the results described in the present study.
In summary, we have shown that opioid peptides can have a marked effect on the function of cardiac myocytes and that this action is mediated by 8-and K-receptor, but not ,u-receptor, stimulation. Thus, neuronal release of opioids not only alters synaptic transmission but may also have a direct effect on myocardial function. Additionally, definite differences exist in the response to the two receptor agonists, and this may affect the physiological role of opioid peptides in vivo. The functional sequelae of an acute exposure to K-agonists, as it may occur during the release of opioids into the synaptic cleft, may differ from those of a more chronic exposure, where opioids reach the myocardium via the systemic circulation.
It is interesting that the results on Ca2' release from an intracellular pool obtained in unstimulated cardiac myocytes could be duplicated in neuronal cells. An increase in Cai, depletion of an intracellular Ca24 pool, and Ca, oscillations may all reflect important mechanisms regulating the activity of the nervous system.6162'69 Thus, coupling between opioid receptors and phosphatidylinositol turnover leading to 1P3 production and changes in cell Ca'4 homeostasis may reflect a general mechanism for the action of K and 6 opioid peptides.
